{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:25:40Z","timestamp":1760783140534},"reference-count":13,"publisher":"CLOCKSS Archive","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HETEROCYCLES"],"published-print":{"date-parts":[[2004]]},"DOI":"10.3987\/com-03-s(p)50","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T03:41:35Z","timestamp":1236224495000},"page":"203","source":"Crossref","is-referenced-by-count":9,"title":["Heterocycle Fused Cyclohexyl-glycine Derivatives as Novel Dipeptidyl Peptidase-IV Inhibitors"],"prefix":"10.13030","volume":"62","author":[{"given":"Anthony","family":"Mastracchio","sequence":"first","affiliation":[]},{"given":"Emma","family":"R. Parmee","sequence":"additional","affiliation":[]},{"given":"Barbara","family":"Leiting","sequence":"additional","affiliation":[]},{"given":"Frank","family":"Marsilio","sequence":"additional","affiliation":[]},{"given":"Reshma","family":"Patel","sequence":"additional","affiliation":[]},{"given":"Nancy","family":"A. Thornberry","sequence":"additional","affiliation":[]},{"given":"Ann","family":"E. Weber","sequence":"additional","affiliation":[]},{"given":"Scott","family":"D. Edmondson","sequence":"additional","affiliation":[]}],"member":"5187","reference":[{"key":"#cr-split#-10.3987\/COM-03-S(P)50-1.1","doi-asserted-by":"crossref","unstructured":"For lead references, see (a) K. Augustyns, P. V. d. Veken, K. Senten, and A. Haemers, Expert Opin. Ther. Patents, 2003, 13, 499.","DOI":"10.1517\/13543776.13.4.499"},{"key":"#cr-split#-10.3987\/COM-03-S(P)50-1.2","doi-asserted-by":"crossref","unstructured":"(b) D. J. Drucker, Expert Opin. Invest. Drugs, 2003, 12, 87.","DOI":"10.1517\/13543784.12.1.87"},{"key":"#cr-split#-10.3987\/COM-03-S(P)50-1.3","doi-asserted-by":"crossref","unstructured":"(c) E. B. Villhauer, J. A. Brinkman, G. B. Naderi, B. F. Burkey, B. E. Dunning, K. Prasad, B. L. Mangold, M. E. Russell, and T. E. Hughes, J. Med. Chem., 2003, 46, 2774.","DOI":"10.1021\/jm030091l"},{"key":"#cr-split#-10.3987\/COM-03-S(P)50-2.1","unstructured":"(a) E. R. Parmee, J. He, A. Mastracchio, S. D. Edmondson, L. Colwell, G. Eiermann, W. P. Feeney, B. Habulihaz, H. He, R. Kilburn, B. Leiting, K. Lyons, F. Marsilio, R. Patel, A. Petrov, J. Di Salvo, J. K. Wu, N. A. Thornberry, and A. E. Weber, submitted to: Bioorganic & Medicinal Chemistry Letters."},{"key":"#cr-split#-10.3987\/COM-03-S(P)50-2.2","unstructured":"(b) C. Caldwell, et. al, manuscript in preparation."},{"key":"#cr-split#-10.3987\/COM-03-S(P)50-3.1","unstructured":"(a) J. A. Joule, \u2018Heterocyclic Chemistry,\u2019 ed. by J. A. Joule and K. Mills, Blackwell Sciences Ltd., Oxford, 2000, pp. 418-422."},{"key":"#cr-split#-10.3987\/COM-03-S(P)50-3.2","unstructured":"(b) L. A. Paquette, \u2018Principles of Modern Heterocyclic Chemistry,\u2019 W. A. Benjamin, Inc., Reading, MA, 1980, pp. 191-194."},{"key":"10.3987\/COM-03-S(P)50-4","doi-asserted-by":"crossref","unstructured":"4. (S)-3-Fluoropyrrolidine was prepared by a modification of the method of G. Giardina, G. Dondio, and M. Grugni, Synlett, 1995, 55. The modification is described in Ref. 2 (c)","DOI":"10.1055\/s-1995-4862"},{"key":"10.3987\/COM-03-S(P)50-5","unstructured":"5. Diastereomeric mixtures were resolved using ChiralCel columns. Type OJ (isocratic method, 50% ethanol\/hexane) was used for 3a and type AS (isocratic method, 50% ethanol\/hexane) was used for 3b."},{"key":"10.3987\/COM-03-S(P)50-6","unstructured":"6. All final products were purified by reverse phase HPLC to afford TFA salts."},{"key":"10.3987\/COM-03-S(P)50-7","unstructured":"7. The two diastereomers of 10 were separated using a ChiralCel column type AD (isocratic method, 75% EtOH\/hexane). The most potent deprotected compound (3d) is derived from the faster eluting isomer."},{"key":"10.3987\/COM-03-S(P)50-8","doi-asserted-by":"crossref","unstructured":"8. For DP-IV assay conditions, see : B. Leiting, K. D. Pryor, J. K. Wu, F. Marsilio, R. A. Patel, C. S. Craik, J. A. Ellman, R. T. Cummings, and N. A. Thornberry, Biochem. J., 2003, 371, 525.","DOI":"10.1042\/bj20021643"},{"key":"10.3987\/COM-03-S(P)50-9","unstructured":"9. The less active diastereomers of 3a and 3b were IC50 = 385 nM and 171 nM respectively."}],"container-title":["HETEROCYCLES"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T20:37:58Z","timestamp":1719261478000},"score":1,"resource":{"primary":{"URL":"https:\/\/triggered.stanford.clockss.org\/ServeContent?doi=10.3987%2Fcom-03-s%28p%2950"},"secondary":[{"URL":"https:\/\/triggered.edinburgh.clockss.org\/ServeContent?doi=10.3987%2Fcom-03-s%28p%2950","label":"edinburgh"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004]]}},"alternative-id":["COM-03-S(P)50"],"URL":"https:\/\/doi.org\/10.3987\/com-03-s(p)50","relation":{},"ISSN":["0385-5414"],"issn-type":[{"type":"print","value":"0385-5414"}],"subject":[],"published":{"date-parts":[[2004]]}}}